EcoDrugPlus

Si:dkey-1h24.2

Ensembl ID : ENSDARG00000074117
Gene Symbol: SI:DKEY-1H24.2
5 Cross references
198 Possible Orthologues:

Si:dkey-211g8.6

Ensembl ID : ENSDARG00000063088
Gene Symbol: SI:DKEY-211G8.6
7 Enzyme and pathways 5 Cross references
319 Possible Orthologues:

Si:dkey-211g8.7

Ensembl ID : ENSDARG00000058535
Gene Symbol: SI:DKEY-211G8.7
7 Enzyme and pathways 5 Cross references
273 Possible Orthologues:

Si:dkey-65b13.9

Ensembl ID : ENSDARG00000105249
Gene Symbol: SI:DKEY-65B13.9
3 Cross references
209 Possible Orthologues:

Si:zfos-1069f5.1

Ensembl ID : ENSDARG00000100890
Gene Symbol: SI:ZFOS-1069F5.1
5 Cross references
206 Possible Orthologues:

Si:zfos-169g10.2

Ensembl ID : ENSDARG00000103662
Gene Symbol: SI:ZFOS-169G10.2
5 Cross references
184 Possible Orthologues:

Sigma Non-Opioid Intracellular Receptor 1

Ensembl ID : ENSDARG00000011418
Gene Symbol: SIGMAR1
5 Cross references
206 Possible Orthologues:

Sirtuin 1

Ensembl ID : ENSDARG00000068064
Gene Symbol: SIRT1
12 Enzyme and pathways 5 Cross references
159 Possible Orthologues:

Smoothened, Frizzled Class Receptor

Ensembl ID : ENSDARG00000002952
Gene Symbol: SMO
9 Enzyme and pathways 5 Cross references
204 Possible Orthologues:

Sodium Channel, Voltage Gated, Type V-Like, Alpha B

Ensembl ID : ENSDARG00000102312
Gene Symbol: SCN5LAB
5 Cross references
263 Possible Orthologues:

Sodium Channel, Voltage Gated, Type Viii, Alpha Subunit A

Ensembl ID : ENSDARG00000005775
Gene Symbol: SCN8AA
3 Enzyme and pathways 5 Cross references
263 Possible Orthologues:

Sodium Channel, Voltage Gated, Type Viii, Alpha Subunit B

Ensembl ID : ENSDARG00000018032
Gene Symbol: SCN8AB
3 Enzyme and pathways 5 Cross references
263 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).